Introducing Eveo® Cell Therapy Platform
Unlock human-centric manufacturing, accelerating your therapy delivery to patients* with a single platform combining process ownership, maximized usability, and built-in commercial-scale readiness.
Sartorius Eveo® Cell Therapy Platform brings together smart automation, quality control, and raw materials for GMP production, empowering cell therapy manufacturers to overcome constraints limiting output.
Sartorius Eveo® Cell Therapy Platform is the only closed, user-owned, modular, multi-parallel intensified processing platform designed for multiple cell therapy product types across both centralized and decentralized manufacturing models*.
Ready to get started?
Click the yellow icons to explore a selection of key features.
Workflow support – Automate your whole process, end to end. Or focus on individual unit operations.
As you need, evolve with Eveo® Cell Therapy Platform.
How Much Could Eveo® Cell Therapy Platform Save You?
Connect with our experts to discover how Eveo® Cell Therapy Platform can transform your organisation. Using our Cost of Goods Calculator, you will gain clear insights into the benefits of the system in the context of your business.
University College London
“We were pleased to see Sartorius advancing a new GMP manufacturing platform for cell therapies. The system was intuitive and easy to use, enabling rapid translation and improvement of our CAR-T process onto the platform. The platform’s integration of automation, parallelisation and process intensification within a compact footprint offers strong potential to address key scalability bottlenecks in cell therapy manufacturing.”
Prof Qasim Rafiq, Professor in Bioprocess Engineering, Vice Dean (Health) in the Faculty of Engineering Sciences and Director of the UCL Institute of Healthcare Engineering.
Dr Pierre Springuel, Post-doctoral Researcher in Bioprocessing of Cellular Immunotherapies, Dept of Biochemical Engineering.
ElevateBio
“ElevateBio is proud to collaborate with Sartorius on the Eveo® platform that provides flexibility, scalability and advanced automation design.
For our manufacturing customers, the Eveo® platform has the potential to deliver remarkable reproducibility while significantly reducing COGs and maximizing output within a small footprint—a true paradigm shift in manufacturing efficiency.”
Mike Paglia, Chief Technology Officer, ElevateBio
Built and Sustained by Trusted Professionals1
Backed by deep experience and a team of recognized experts1, we apply automation to streamline biological processes, providing sustained support for development and manufacturing worldwide.
We share your goals to make cell therapy more affordable and accessible for all. With over 150 years of innovation and a commitment to bioprocessing excellence, we are dedicated to your cell therapy success.
Ready to get started, or keen to stay informed?
References & Notes
1. ESACT (2022) Innovation Award 2022. Available at: https://esact.org/activities/innovation-award/
*The Eveo® Cell Therapy platform is for manufacturing use only. Any clinical application of the target cells is exclusively within the responsibility of the user.